ArticleJournal of stroke2023

Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial.

Keun-Sik Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.